AZD4547 (Astra Zeneca) is a pan-FGFR inhibitor in Phase I cl...

created [InstanceEdit:2077539] Rothfels, K, 2012-01-27
dbId 2077540
displayName AZD4547 (Astra Zeneca) is a pan-FGFR inhibitor in Phase I cl...
schemaClass Summation
text AZD4547 (Astra Zeneca) is a pan-FGFR inhibitor in Phase I clinical trials for patients with advanced gastric cancer (NCT01457846) and for patient with advanced solid tumors with or without amplified FGFR1 or 2 (NCT00979134) and in Phase I/II trials for breast cancer patients with FGFR1 amplifications (NCT01202591).
Cite Us!